Education
About Us
Working with TipRanks
Follow Us
Staar Surgical (STAA)
NASDAQ:STAA
STAA Stock Chart & Stats
$25.25
-$1.18(-4.94%)
At close: 4:00 PM EST
$25.25
-$1.18(-4.94%)
Day’s Range― - ―
52-Week Range$13.50 - $32.00
Previous CloseN/A
Volume326.32K
Average Volume (3M)1.07M
Market Cap
$1.25B
Enterprise ValueN/A
Total Cash (Recent Filing)$189.88B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.84
Next Earnings
Feb 25, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.34
Shares Outstanding49,354,122
10 Day Avg. Volume1,097,174
30 Day Avg. Volume1,067,253
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)2.99
Price to Sales (P/S)3.79
P/FCF Ratio-155.08
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$28.00Price Target Upside10.89% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Earnings BeatSTAAR Surgical announced preliminary Q3 results with net sales of $94.7M, which is ahead of the $90.1M estimate and the consensus of $92.6M.
Inventory ManagementDistributor inventory in China has returned to historical levels and management continues to expect China sales to normalize.
Revenue GrowthGrowth in the quarter was driven by a 7.7% increase in sales outside of China.
Bears Say
Acquisition UncertaintyThe next step ahead for the stock will be the Thursday special shareholder meeting to vote on the highly contested merger proposal, which adds uncertainty.
Strategic DelaysThe shareholder vote has been rescheduled, indicating potential delays in strategic plans.
Weak China MarketThe true picture of end-market demand in China shows a major decline despite a slight improvement from the previous quarter.
Staar Surgical News
STAA FAQ
What was Staar Surgical’s price range in the past 12 months?
Staar Surgical lowest stock price was $13.50 and its highest was $32.00 in the past 12 months.
What is Staar Surgical’s market cap?
Staar Surgical’s market cap is $1.25B.
When is Staar Surgical’s upcoming earnings report date?
Staar Surgical’s upcoming earnings report date is Feb 25, 2026 which is in 110 days.
How were Staar Surgical’s earnings last quarter?
Staar Surgical released its earnings results on Oct 29, 2025. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.246 by $0.094.
Is Staar Surgical overvalued?
According to Wall Street analysts Staar Surgical’s price is currently Undervalued.
Does Staar Surgical pay dividends?
Staar Surgical does not currently pay dividends.
What is Staar Surgical’s EPS estimate?
Staar Surgical’s EPS estimate is 0.1.
How many shares outstanding does Staar Surgical have?
Staar Surgical has 49,354,122 shares outstanding.
What happened to Staar Surgical’s price movement after its last earnings report?
Staar Surgical reported an EPS of $0.34 in its last earnings report, beating expectations of $0.246. Following the earnings report the stock price went down -2.099%.
Which hedge fund is a major shareholder of Staar Surgical?
Currently, no hedge funds are holding shares in STAA
Staar Surgical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$28.00 (10.89% Upside)
$28.00 (10.89% Upside)
Blogger Sentiment
Bullish
STAA Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 720.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 3.2%
Last 30 Days ▼ 3.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.24%
12-Months-Change
Fundamentals
Return on Equity
-25.55%
Trailing 12-Months
Asset Growth
-14.62%
Trailing 12-Months
Company Description
Staar Surgical
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
STAA Stock 12 Month Forecast
Average Price Target
$28.00
▲(10.89% Upside)
Technical Analysis
Ownership Overview
55.45% Insiders
13.98% Mutual Funds
0.03% Other Institutional Investors
5.83% Public Companies and
Individual Investors